GTS SECURITIES LLC
Broker-DealerPosition in PMVP — PMV Pharmaceuticals, Inc.
CIK 1452765
NEW YORK, NY
Position in PMVP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,401
-$101 QoQ
Shares Held
10,001
-0.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GTS SECURITIES LLC holds $7,337,364 across 30 Biotechnology names. PMVP ranks #30 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,738 | $776,086 | |
| 2 | ACLX |
Arcellx, Inc.
|
6,338 | $727,729 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
|
15,604 | $627,748 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
767 | $592,614 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
7,787 | $370,427 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,052 | $348,075 | |
| 7 | INSM |
INSMED Inc
|
1,991 | $325,568 | |
| 8 | ABVX |
Abivax S.A.
|
2,652 | $295,300 |
All Filings in PMVP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,401 | 10,001 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,502 | 10,002 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $14,001 | 10,001 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||